Related Experiment Video
Updated: Jul 9, 2025

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
8.2K
Rates of New Peanut Allergy and Discontinuation Following Introduction in High-Risk Infants
Abhilasha Banerjee1, Robert Wood1, Joan Dunlop1
1Department of Pediatrics, Johns Hopkins University, Baltimore, Md.
The Journal of Allergy and Clinical Immunology. in Practice
|November 30, 2023
Summary
High-risk infants showed low rates of new peanut allergy (2%) and discontinuation after introduction. Families need support, especially with existing peanut allergies in the household.
Area of Science:
- Pediatric Allergy and Immunology
- Food Allergy Prevention
- Infant Nutrition
Background:
- Current guidelines recommend weekly peanut protein introduction for high-risk infants to prevent peanut allergy.
- Adherence and incidence of new peanut allergy post-introduction require further investigation.
Purpose of the Study:
- To assess compliance with peanut introduction guidelines in high-risk infants.
- To determine the rates of new peanut allergy development.
- To identify reasons for discontinuing peanut consumption.
Main Methods:
- A prospective cohort study followed 277 high-risk infants (4-11 months) with no prior peanut exposure.
- Infants were recommended 6g of peanut protein weekly and followed to 30 months via in-person visits and questionnaires.
Main Results:
- 88% of infants consumed some peanut protein, with a median weekly intake of 3g.
- New peanut allergy developed in 2% of infants; food protein-induced enterocolitis syndrome was noted in 2 cases.
- Fear of reaction in other family members was the primary reason for discontinuation.
Conclusions:
- Low rates of new peanut allergy and discontinuation were observed in this high-risk cohort.
- Families, particularly those with existing peanut allergies, need substantial support for successful peanut introduction.
Related Concept Videos
Allergic Reactions
27.5K
Overview
27.5K
Development of Immunocompetence
315
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
315
Hypersensitivities
676
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
676
Desensitization and Tachyphylaxis
1.8K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.8K
Allergic Drug Reactions
847
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
847
Pharmacovigilance
850
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
850

